SONNET BIOTHERAPEUTICS HOLDINGS, INC. Research and Development Expense
SONNET BIOTHERAPEUTICS HOLDINGS, INC. reported Research and Development Expense of $8.36 million for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-16.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2025-12-16
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. research and development expense for the quarter ending 2025-09-30 was $2.16M, a 80.06% increase year-over-year.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. research and development expense for the quarter ending 2025-06-30 was $2.43M, a 40.45% increase year-over-year.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. research and development expense for the quarter ending 2025-03-31 was $1.88M, a 13.03% decline year-over-year.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. research and development expense for the quarter ending 2024-12-31 was $1.89M, a 192.85% increase year-over-year.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. research and development expense for fiscal 2025 was $8.36M, a 45.63% increase from fiscal 2024.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. research and development expense for fiscal 2024 was $5.74M, a 51.44% decline from fiscal 2023.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. research and development expense for fiscal 2023 was $11.81M, a 44.90% decline from fiscal 2022.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. research and development expense for fiscal 2022 was $21.44M, a 28.91% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2025-09-30 | $2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-16 | $4.58M derived: sum of 2 quarters · filed 2025-12-16 | $6.47M derived: sum of 3 quarters · filed 2025-12-16 | $8.36M 10-K · filed 2025-12-16 |
| 2025-06-30 | $2.43M 10-Q · filed 2025-08-13 | $4.31M derived: sum of 2 quarters · filed 2025-08-13 | $6.20M 10-Q · filed 2025-08-13 | $7.40M derived: sum of 4 quarters · filed 2025-12-16 |
| 2025-03-31 | $1.88M 10-Q · filed 2025-05-13 | $3.77M 10-Q · filed 2025-05-13 | $4.97M derived: sum of 3 quarters · filed 2025-12-16 | $6.70M derived: sum of 4 quarters · filed 2025-12-16 |
| 2024-12-31 | $1.89M 10-Q · filed 2025-02-13 | $3.08M derived: sum of 2 quarters · filed 2025-12-16 | $4.81M derived: sum of 3 quarters · filed 2025-12-16 | $6.98M derived: sum of 4 quarters · filed 2025-12-16 |
| 2024-09-30 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-16 | $2.93M derived: sum of 2 quarters · filed 2025-12-16 | $5.09M derived: sum of 3 quarters · filed 2025-12-16 | $5.74M 10-K · filed 2025-12-16 |
| 2024-06-30 | $1.73M 10-Q · filed 2025-08-13 | $3.89M derived: sum of 2 quarters · filed 2025-08-13 | $4.54M 10-Q · filed 2025-08-13 | $6.38M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $2.17M 10-Q · filed 2025-05-13 | $2.81M 10-Q · filed 2025-05-13 | $4.65M derived: sum of 3 quarters · filed 2025-05-13 | $7.06M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $644.04K 10-Q · filed 2025-02-13 | $2.49M derived: sum of 2 quarters · filed 2025-02-13 | $4.90M derived: sum of 3 quarters · filed 2025-02-13 | $8.71M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-09-30 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-17 | $4.25M derived: sum of 2 quarters · filed 2024-12-17 | $8.07M derived: sum of 3 quarters · filed 2024-12-17 | $11.81M 10-K · filed 2024-12-17 |
| 2023-06-30 | $2.41M 10-Q · filed 2024-08-14 | $6.23M derived: sum of 2 quarters · filed 2024-08-14 | $9.97M 10-Q · filed 2024-08-14 | $15.10M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $3.82M 10-Q · filed 2024-05-14 | $7.56M 10-Q · filed 2024-05-14 | $12.69M derived: sum of 3 quarters · filed 2024-05-14 | $18.34M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $3.75M 10-Q · filed 2024-02-14 | $8.87M derived: sum of 2 quarters · filed 2024-02-14 | $14.52M derived: sum of 3 quarters · filed 2024-02-14 | $20.92M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-09-30 | $5.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-14 | $10.77M derived: sum of 2 quarters · filed 2023-12-14 | $17.18M derived: sum of 3 quarters · filed 2023-12-14 | $21.44M 10-K · filed 2023-12-14 |
| 2022-06-30 | $5.65M 10-Q · filed 2023-08-14 | $12.05M derived: sum of 2 quarters · filed 2023-08-14 | $16.32M 10-Q · filed 2023-08-14 | $21.36M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $6.41M 10-Q · filed 2023-05-10 | $10.67M 10-Q · filed 2023-05-10 | $15.71M derived: sum of 3 quarters · filed 2023-05-10 | $19.59M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $4.27M 10-Q · filed 2023-02-13 | $9.30M derived: sum of 2 quarters · filed 2023-02-13 | $13.19M derived: sum of 3 quarters · filed 2023-02-13 | $17.03M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-09-30 | $5.04M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-15 | $8.92M derived: sum of 2 quarters · filed 2022-12-15 | $12.76M derived: sum of 3 quarters · filed 2022-12-15 | $16.63M 10-K · filed 2022-12-15 |
| 2021-06-30 | $3.89M 10-Q · filed 2022-08-15 | $7.73M derived: sum of 2 quarters · filed 2022-08-15 | $11.60M 10-Q · filed 2022-08-15 | $16.30M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $3.84M 10-Q · filed 2022-05-10 | $7.71M 10-Q · filed 2022-05-10 | $12.42M derived: sum of 3 quarters · filed 2022-05-10 | $14.87M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $3.87M 10-Q · filed 2022-02-08 | $8.58M derived: sum of 2 quarters · filed 2022-02-08 | $11.03M derived: sum of 3 quarters · filed 2022-02-08 | $12.34M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-09-30 | $4.71M derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-17 | $7.17M derived: sum of 2 quarters · filed 2020-12-17 | $8.47M derived: sum of 3 quarters · filed 2021-05-17 | $9.88M 10-K · filed 2020-12-17 |
| 2020-06-30 | $2.46M 10-Q · filed 2020-08-14 | $3.76M derived: sum of 2 quarters · filed 2021-05-17 | $5.17M 10-Q · filed 2020-08-14 | $6.75M derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-03-31 | $1.30M 10-Q · filed 2021-05-17 | $2.71M 10-Q · filed 2021-05-17 | $4.29M derived: sum of 3 quarters · filed 2021-05-17 | $4.69M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $1.41M 10-Q · filed 2021-02-16 | $2.99M derived: sum of 2 quarters · filed 2021-02-16 | $3.38M derived: sum of 3 quarters · filed 2021-02-16 | |
| 2019-09-30 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-17 | $1.97M derived: sum of 2 quarters · filed 2020-12-17 | $2.20M 10-K · filed 2020-12-17 | |
| 2019-06-30 | $391.91K 10-Q · filed 2020-08-14 | $616.33K 10-Q · filed 2020-08-14 |